Fibrosis and matrix metalloproteinases in rat renal allografts

Transplant International

Volumn 18, Issue 5, 2005, Pages 506-512

  Inkinen, Kaija A ^a   Soots, Anu P ^a   Krogerus, Leena A ^a   Lautenschlager, Irmeli T ^a   Ahonen, Juhani P ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Chronic rejection; Collagens; Fibrosis; Kidney transplantation; Matrix metalloproteinases; Tissue inhibitors of matrix metalloproteinases

Indexed keywords

COLLAGEN; GELATINASE A; GELATINASE B; MESSENGER RNA; TISSUE INHIBITOR OF METALLOPROTEINASE 3; METALLOPROTEINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOGRAFT; CHRONIC ALLOGRAFT NEPHROPATHY; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; GENE EXPRESSION; GENE LOCATION; GLOMERULUS; HISTOLOGY; IN SITU HYBRIDIZATION; KIDNEY ALLOGRAFT; KIDNEY FIBROSIS; KIDNEY TRANSPLANTATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; ZYMOGRAPHY; ALLOTRANSPLANTATION; ANIMAL; AUTOTRANSPLANTATION; BIOSYNTHESIS; BROWN NORWAY RAT; FIBROSIS; GENETICS; METABOLISM; PATHOLOGY; PHYSIOLOGY; RAT STRAIN;

ANIMALS; COLLAGEN; FIBROSIS; GENE EXPRESSION; IN SITU HYBRIDIZATION; KIDNEY TRANSPLANTATION; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; METALLOPROTEASES; RATS; RATS, INBRED BN; RATS, INBRED STRAINS; RNA, MESSENGER; TISSUE INHIBITOR OF METALLOPROTEINASE-3; TRANSPLANTATION, AUTOLOGOUS; TRANSPLANTATION, HOMOLOGOUS;

EID: 23844520998     PISSN: 09340874     EISSN: 14322277     Source Type: Journal    
DOI: 10.1111/j.1432-2277.2004.00053.x     Document Type: Article

References (29)

1. Paul LC. Chronic allograft nephropathy: an update. Kidney Int 1999; 56: 783.
2. Soots A, Lautenschlager I, Krogerus L, Saarinen O, Ahonen J. An experimental model of chronic renal allograft rejection in the rat using triple drug immunosuppression. Transplantation 1998; 65: 42.
3. Inkinen K, Soots A, Krogerus L, Bruggeman C, Ahonen J, Lautenschlager I. Cytomegalovirus increases collagen synthesis in chronic rejection in the rat. Nephrol Dial Transplant 2002; 17: 772.
4. Jones CL, Buch S, Post M, McCulloch L, Liu E, Eddy AA. Pathogenesis of interstitial fibrosis in chronic purine aminonucleoside nephrosis. Kidney Int 1991; 40: 1020.
5. Floege J, Johnson RJ, Gordon K, et al. Altered glomerular extracellular matrix synthesis in experimental membranous nephropathy. Kidney Int 1992; 42: 573.
6. Furness PN. Extracellular matrix and the kidney. J Clin Pathol 1996; 49: 355.
7. Duymelinck C, Deng JT, Dauwe SE, De Broe ME, Verpooten GA. Inhibition of the matrix metalloproteinase system in a rat model of chronic cyclosporine nephropathy. Kidney Int 1998; 54: 804.
8. Norman JT, Lewis MP. Matrix metalloproteinases (MMPs) in renal fibrosis. Kidney Int Suppl 1996; 54: S61.
9. Khanna A, Plummer M, Bromberek C, Bresnahan B, Hariharan S. Expression of TGF-beta and fibrogenic genes in transplant recipients with tacrolimus and cyclosporine nephrotoxicity. Kidney Int 2002; 62: 2257.
10. Becker BN, Jacobson LM, Becker YT, et al. Renin-angiotensin system gene expression in post-transplant hypertension predicts allograft function. Transplantation 2000; 69: 1485.
11. Rodrigo E, Lopez-Hoyos M, Escallada R, et al. Circulating levels of matrix metalloproteinases MMP-3 and MMP-2 in renal transplant recipients with chronic transplant nephropathy. Nephrol Dial Transplant 2000; 15: 2041.
12. Bicknell GR, Williams ST, Shaw JA, Pringle JH, Furness PN, Nicholson ML. Differential effects of cyclosporin and tacrolimus on the expression of fibrosis-associated genes in isolated glomeruli from renal transplants. Br J Surg 2000; 87: 1569.
13. Nicholson ML, Waller JR, Bicknell GR. Renal transplant fibrosis correlates with intragraft expression of tissue inhibitor of metalloproteinase messenger RNA. Br J Surg 2002; 89: 933.
14. Davies M, Martin J, Thomas GJ, Lovett DH. Proteinases and glomerular matrix turnover. Kidney Int 1992; 41: 671.
15. Bond M, Fabunmi RP, Baker AH, Newby AC. Synergistic upregulation of metalloproteinase-9 by growth factors and inflammatory cytokines: an absolute requirement for transcription factor NF-kappa B. FEBS Lett 1998; 435: 29.
16. Salo T, Lyons JG, Rahemtulla F, Birkedal-Hansen H, Larjava H. Transforming growth factor-beta 1 up-regulates type IV collagenase expression in cultured human keratinocytes. J Biol Chem 1991; 266: 11436.
17. Gomez DE, Alonso DF, Yoshiji H, Thorgeirsson UP. Tissue inhibitors of metalloproteinases: structure, regulation and biological functions. Eur J Cell Biol 1997; 74: 111.
18. Wu I, Moses MA. Cloning and expression of the cDNA encoding rat tissue inhibitor of metalloproteinase 3 (TIMP-3). Gene 1996; 168: 243.
19. Leco KJ, Waterhouse P, Sanchez OH, et al. Spontaneous air space enlargement in the lungs of mice lacking tissue inhibitor of metalloproteinases-3 (TIMP-3). J Clin Invest 2001; 108: 817.
20. Solez K, Axelsen RA, Benediktsson H, et al. International standardization of criteria for the histologic diagnosis of renal allograft rejection: the Banff working classification of kidney transplant pathology. Kidney Int 1993; 44: 411.
21. Isoniemi HM, Krogerus L, von Willebrand E, Taskinen E, Ahonen J, Häyry P. Histopathological findings in well-functioning, long-term renal allografts. Kidney Int 1992; 41: 155.
22. Inkinen K, Wolff H, von Boguslawski K, Ahonen J. Type V collagen in experimental granulation tissue. Connect Tissue Res 1998; 39: 281.
23. Inkinen K, Turakainen H, Wolff H, Ravanti L, Kähäri VM, Ahonen J. Expression and activity of matrix metalloproteinase-2 and -9 in experimental granulation tissue. Apmis 2000; 108: 318.
24. Apte SS, Mattei MG, Olsen BR. Cloning of the cDNA encoding human tissue inhibitor of metalloproteinases-3 (TIMP-3) and mapping of the TIMP3 gene to chromosome 22. Genomics 1994; 19: 86.
25. Inkinen K, Turakainen H, Wolff H, Ahonen J. Cloning of cDNA for rat pro alpha1(V) collagen mRNA. Expression patterns of type I, type III and type V collagen genes in experimental granulation tissue. Connect Tissue Res 1999; 40: 209.
26. Lichtinghagen R, Huegel O, Seifert T, et al. Expression of matrix metalloproteinase-2 and -9 and their inhibitors in peripheral blood cells of patients with chronic hepatitis C. Clin Chem 2000; 46: 183.
27. Esparza J, Vilardell C, Calvo J, et al. Fibronectin upregulates gelatinase B (MMP-9) and induces coordinated expression of gelatinase A (MMP-2) and its activator MT1-MMP (MMP-14) by human T lymphocyte cell lines. A process repressed through RAS/MAP kinase signaling pathways. Blood 1999; 94: 2754.
28. Zeisberg M, Maeshima Y, Mosterman B, Kalluri R. Renal fibrosis. Extracellular matrix microenvironment regulates migratory behavior of activated tubular epithelial cells. Am J Pathol 2002; 160: 2001.
29. Fata JE, Leco KJ, Voura EB, et al. Accelerated apoptosis in the Timp-3-deficient mammary gland. J Clin Invest 2001; 108: 831.